Cramer's Buy Recommendations: Pfizer, CrowdStrike, Lowe's

Jim Cramer recommends buying Lowe's, saying Marvin Ellison is doing his best. Cramer also comments on Pfizer and CrowdStrike, suggesting waiting for more information on Pfizer's Seagen acquisition and taking profits from CrowdStrike.

Jim Cramer, a prominent financial commentator, has recommended investing in Lowe's Companies (LOW) while also offering insights on Pfizer and CrowdStrike. Cramer praised Marvin Ellison, the CEO of Lowe's, for his efforts, suggesting that the company's performance aligns with expectations. On July 22, 2025, Guggenheim reaffirmed its "Buy" rating for Lowe's, maintaining a price target of $300.00 USD [1]. This reflects continued confidence in Lowe's market position and stable outlook from Guggenheim analysts.

Cramer also discussed Pfizer, noting that more information is needed regarding the company's acquisition of Seagen. He advised investors to wait for further details before making decisions. Additionally, Cramer suggested taking profits from CrowdStrike, as the company's stock has seen significant growth.

In another development, Jim Cramer has expressed concern over the rising U.S. national debt, which has surpassed $38 trillion. He mentioned that some investors are buying Bitcoin as a hedge against increasing debt [3]. Cramer's comments come amidst a climb in U.S. Treasury yields, indicating investor anxiety over inflation and government spending.

References:
[1] https://www.gurufocus.com/news/2994287/lowes-companies-low-receives-reiterated-buy-rating-from-guggenheim-low-stock-news
[3] https://finance.yahoo.com/news/jim-cramer-harsh-response-soaring-214143453.html